Eye Neoplasm - Retinoblastoma
NCT00072384
Clinical Trial Information
Trial Number: NCT00072384 (ClinicalTrials.gov)
Disease Type:
- Eye Neoplasm - Retinoblastoma
Trial Title:
A Single Arm Trial of Systemic and Subtenon Chemotherapy for Groups C and D Intraocular Retinoblastoma
Study ID:
ARET0231
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00072384-D5 | NCT00072384 - D5 Dataset Description: NCT00072384 – D5 is one of 5 data submissions associated with PubMed ID 32589362. This dataset provides the information for delays in treatment. It is used to generate data reported at the end of Section 3.5, Systemic Toxicity. |
| NCT00072384-D4 | NCT00072384 - D4 Dataset Description: NCT00072384 – D4 is one of 5 data submissions associated with PubMed ID 32589362. This dataset provides the information for the specific toxicities that occurred during protocol therapy. There is one row per patient/toxicity term. |
| NCT00072384-D3 | NCT00072384 - D3 Dataset Description: NCT00072384 – D3 is one of 5 data submissions associated with PubMed ID 32589362. This dataset provides the information of the primary outcome data, i.e. whether event occurred within 1 year since enrollment along with other details. There is one row for each eye. It is used to generate a summary of patient presentation and failure event (Table 3) and the information at the end of Section 3 Results. |
| NCT00072384-D2 | NCT00072384 - D2 Dataset Description: NCT00072384 – D2 is one of 5 data submissions associated with PubMed ID 32589362. This dataset provides detailed eye-level local therapy information for each cycle. It is used to generate Ophthalmology treatment details for the 29 Group C/D eyes (Table 2). |
| NCT00072384-D1 | NCT00072384 - D1 Dataset Description: NCT00072384 - D1 is one of 5 data submissions associated with PubMed ID 32589362. This dataset provides the information for patients who were enrolled on ARET0231. There is one row for each patient enrolled. The dataset provides the information of baseline characteristics, eye stage from local and central review, outcome data and ocular toxicity on ARET0231 as reported in the manuscript. It is used to generate the Summary of Baseline Characteristics for eligible patients (Table 1), and the information in the beginning of Section 3 Results, Section 3.2 Patterns of intraocular recurrence, Section 3.3 Extraocular recurrence/deaths, and Section 3.4 Ocular toxicity. |
NCT00335738
Clinical Trial Information
Trial Number: NCT00335738 (ClinicalTrials.gov)
Disease Type:
- Eye Neoplasm - Retinoblastoma
Trial Title:
A Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy
Study ID:
ARET0332
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00335738-D2 | NCT00335738-D2 is one of 2 data submissions associated with PubMed ID 31539297. This dataset provides the information for the specific toxicities that occurred during protocol therapy. There is one row per patient/toxicity term. Each row has the maximum grade of the particular toxicity term observed during the patient’s protocol treatment. |
| NCT00335738-D1 | NCT00335738-D1 is one of 2 data submissions associated with PubMed ID 31539297. There is one row for each patient enrolled. The dataset provides the information of consort flow of patient enrollment, baseline characteristics, central pathology review results, and outcome data on ARET0332 as reported in the manuscript. |
NCT00079417
Clinical Trial Information
Trial Number: NCT00079417 (ClinicalTrials.gov)
Disease Type:
- Eye Neoplasm - Retinoblastoma
Trial Title:
Trial of Systemic Neoadjuvant Chemotherapy for Group B Intraocular Retinoblastoma
Study ID:
ARET0331
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00079417-D3 | NCT00079417-D3 Only patients who are contributed to the analysis, that is, those with analysiset = 1 in the dataset NCT00079417-D1, are represented in the dataset. For each patient, ophthalmological response after 1 cycle and at the end of therapy are presented in the relevant column. The data presented in the second paragraph of Section 3.2 can be derived from the noted dataset. |
| NCT00079417-D2 | NCT00079417-D2 Only patients who are contributed to the analysis, that is, those with analysiset = 1 in the dataset NCT00079417-D1, are represented in the dataset. For each patient, the presence of each type of toxicity at any time during protocol therapy is identified in the relevant column. These data appear in section 3.3 of the manuscript. |
| NCT00079417-D1 | NCT00079417-D1 Blanks represent missing data or not applicable for analysis. The CONSORT diagram (manuscript Figure 2) can be reconstructed with the variable consort1 through consort4. The dataset contains one line for every patient enrolled on ARET0331. Table 1, Table 2, Figure 3 and the cumulative incidence calculations can be calculated from this data set. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®